Lindus Health
Clinical trials / CRO tech, London
Tech-enabled 'anti-CRO' running faster, cheaper clinical trials end to end. It raised $55m in its Series B in January 2025. It has 4 roles open, 2 of them in the UK.
Backed by Balderton Capital, Creandum and Firstminute Capital. Total raised ~$75m.
On the Home Office register of licensed visa sponsors.
- 31 daystypical age of an open role
- 0roles open for more than 60 days
- 2roles taken down since we started tracking
- 0%of roles list a salary
Open roles
4 live todayOpen roles over time
Hiring momentum
Roles per weekAdded (by posting date)Closed (removed from the board)In the news (hover for headline)
Open roles by function
Open roles by team
As the company labels themIn the news
All 19 stories- AcquisitionPR Newswire, 18 Aug 2026Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
- OtherClay, 20 Apr 2026How Much Did Lindus Health Raise? Funding & Key Investors
- Profiles & interviewsUnite.AI, 13 Apr 2026Nijat Hasanli, Head of Product at Lindus Health – Interview Series
- OtherThe Times, 16 Jan 2026Lindus Health
- OtherGenomeWeb, 9 Jan 2026Lindus Health: Paul Billings
- Partnerships & dealsLelezard, 8 Jan 2026Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board